Alps Advisors Inc Cooper Companies, Inc. Transaction History

Alps Advisors Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$301.4 - $428.42 $2,712 - $3,855	-9 Reduced 1.01%	884 $277,000
Q1 2022 May 16, 2022	BUY	$379.46 - $424.54 $20,490 - $22,925	54 Added 6.44%	893 $373,000
Q4 2021 Feb 09, 2022	BUY	$373.53 - $434.12 $5,976 - $6,945	16 Added 1.94%	839 $351,000
Q3 2021 Nov 15, 2021	SELL	$396.76 - $455.92 $24,995 - $28,722	-63 Reduced 7.11%	823 $340,000
Q1 2021 May 07, 2021	BUY	$357.26 - $392.57 $316,532 - $347,817	886 New	886 $340,000
Q3 2020 Nov 04, 2020	SELL	$280.08 - $347.78 $204,738 - $254,227	-731 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$270.93 - $320.3 $22,758 - $26,905	-84 Reduced 10.31%	731 $207,000
Q1 2020 May 06, 2020	SELL	$243.44 - $359.98 $79,848 - $118,073	-328 Reduced 28.7%	815 $225,000
Q4 2019 Feb 07, 2020	SELL	$281.18 - $322.05 $14,340 - $16,424	-51 Reduced 4.27%	1,143 $367,000
Q3 2019 Nov 04, 2019	BUY	$294.25 - $341.49 $351,334 - $407,739	1,194 New	1,194 $355,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.